Voyager Therapeutics, Inc. (VYGR) earnings
Quarterly results of Voyager Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Voyager Therapeutics, Inc. was expected to report around November 9, 2026; nothing is on file with the SEC yet.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) Voyager Therapeutics, Inc. reported revenue of $4M (-70% on the same quarter a year earlier) and a net loss of $24.7M.
Diluted earnings per share were -$0.40.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | $4M | -70% | -$24.7M | -$0.40 |
| Q2 FY2026 | $3.2M | -39.1% | -$24.5M | -$0.40 |
| Q1 FY2026 | $2.6M | -59.9% | -$27.9M | -$0.47 |
| Q4 FY2025 | $15.3M | +144.3% | -$27.4M | - |
| Q3 FY2025 | $13.4M | - | -$27.9M | -$0.47 |
| Q2 FY2025 | $5.2M | - | -$33.4M | -$0.57 |
| Q1 FY2025 | $6.5M | - | -$31M | -$0.53 |
| Q4 FY2024 | $6.3M | - | -$34.5M | - |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
When is Voyager Therapeutics, Inc.'s next earnings date?
Voyager Therapeutics, Inc. was expected to report around November 9, 2026; nothing is on file with the SEC yet.
What were Voyager Therapeutics, Inc.'s latest quarterly results?
For Q3 FY2026, which ended September 30, 2026, Voyager Therapeutics, Inc. reported revenue of $4M and a net loss of $24.7M. The figures come from its filing with the SEC.
Is Voyager Therapeutics, Inc.'s revenue growing?
Revenue in Q3 FY2026 was $4M, down 70% from $13.4M in the same quarter a year earlier.
Get an email when VYGR reports
Follow VYGR and we email you its next results the day they are filed, with the numbers explained.